app

Spotlight On

Tardive Dyskinesia

More in Tardive Dyskinesia

Assessing Tardive Dyskinesia Risk

Any patient on a dopamine blocker may develop TD

Sep 05, 2024
A computer rendering of dopamine and a dopamine receptor.
Treatment of Tardive Dyskinesia

Until 2017, no FDA approved options existed for serious side effect of dopamine-blocking drugs

Aug 13, 2024
A computer rendering of postsynaptic neuron receptors receiving emitted neurotransmitters from presynaptic neuron
Monitoring for Tardive Dyskinesia in Patients on Antipsychotics

Clinicians need to rely on prescribing practices that minimize risk of development, says expert

Aug 13, 2024
A close up photo of a blisterpack of pills.

1.00 CME Credits
Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA)

0.50 CME Credits
Overcoming Obstacles to Quality Care for Psoriasis Patients in Rural Communities: Key Insights From a Project ECHO Initiative

0.50 CME Credits
Breaking Through Barriers to Achieving Optimal Outcomes for Psoriatic Arthritis Patients in Rural Communities: Key Takeaways From a Project ECHO Initiative

0.25 CME Credits
Leveraging the Latest Data to Guide Precision Medicine in Rheumatoid Arthritis

0.50 CME Credits
Developing Patient-Centered Approaches to Optimize the Management of Bipolar I Disorder

0.50 CME Credits
Integrating Current and Emerging Evidence on Bipolar I Disorder to Personalize Patient Care

2.00 CME Credits
Appropriate Healthcare Interventions in Elder, Child, and Intimate Partner Abuse

3.00 CME Credits
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain